EnsoData has revealed its AI solution for exploring the role of sleep in human health and the diseases it may entail, which is a crucial in addressing healthcare issues such as access to primary care, affordability, and workforce burnout. This artificial intelligence solution will assist in the detection of sleep apnea, a disease that is otherwise undiagnosed. EnsoData is rapidly offering AI-driven solutions and has helped over 50,000 patients in collaboration with 100 provider organisations across the US. The firm has closed a deal at $20 million Series A extension, with Inspire Medical Systems as the primary lead while also including investors Zetta Venture Partners, Venture Investors, Supermoon Capital, Colle Capital, HealthX Ventures, M25 Ventures.
Read More from AITHORITY
